11/04/2024 | Press release | Distributed by Public on 11/04/2024 16:26
Three Months Ended | ||||
September 30, | ||||
(Amounts in Thousands, except EPS) | 2024 | 2023 | ||
Net Sales | $ | 374,256 | $ | 438,081 |
Operating Income
|
$ | 9,115 | $ | 19,490 |
Adjusted Operating Income (non-GAAP) (1)
|
$ | 12,590 | $ | 21,006 |
Operating Income % | 2.4 | % | 4.4 | % |
Adjusted Operating Income (non-GAAP) % | 3.4 | % | 4.8 | % |
Net Income | $ | 3,154 | $ | 10,754 |
Adjusted Net Income (non-GAAP) (1)
|
$ | 5,527 | $ | 12,038 |
Diluted EPS
|
$ | 0.12 | $ | 0.43 |
Adjusted Diluted EPS (non-GAAP) (1)
|
$ | 0.22 | $ | 0.48 |
Three Months Ended | ||||||||||
September 30, | ||||||||||
(Amounts in Millions) | 2024 | * | 2023 | * | Percent Change | |||||
Automotive
|
$ | 188.4 | 50 | % | $ | 212.5 | 49 | % | (11) | % |
Medical
|
89.8 | 24 | % | 102.4 | 23 | % | (12) | % | ||
Industrial excluding AT&M (1)
|
94.0 | 25 | % | 112.9 | 26 | % | (17) | % | ||
Net Sales excluding AT&M (1)
|
$ | 372.2 | 99 | % | $ | 427.8 | 98 | % | (13) | % |
AT&M (1)
|
2.1 | 1 | % | 10.3 | 2 | % | (80) | % | ||
Total Net Sales | $ | 374.3 | $ | 438.1 | (15) | % | ||||
*As a percent of Total Net Sales
|
||||||||||
(1) Sales from our Automation, Test, and Measurement business (AT&M), which was divested effective July 31, 2024, were previously included in the Industrial vertical
|
||||||||||
-Automotive includes electronic power steering, body controls, automated driver assist systems, and electronic braking systems
|
||||||||||
-Medical includes sleep therapy and respiratory care, image guided therapy, in vitro diagnostics, drug delivery, AED, and patient monitoring
|
||||||||||
-Industrial includes climate controls, automation controls, and public safety
|
Conference Call / Webcast | |
Date: | November 5, 2024 |
Time: | 10:00 AM Eastern Time |
Live Webcast: | investors.kimballelectronics.com/events-and-presentations/events |
Dial-In #: |
877-407-8293 (or 201-689-8349)
|
Condensed Consolidated Statements of Income | ||||||||
(Unaudited) | Three Months Ended | |||||||
(Amounts in Thousands, except Per Share Data) | September 30, 2024 | September 30, 2023 | ||||||
Net Sales | $ | 374,256 | 100.0 | % | $ | 438,081 | 100.0 | % |
Cost of Sales | 350,656 | 93.7 | % | 402,539 | 91.9 | % | ||
Gross Profit | 23,600 | 6.3 | % | 35,542 | 8.1 | % | ||
Selling and Administrative Expenses | 13,427 | 3.6 | % | 16,052 | 3.7 | % | ||
Restructuring Expense | 2,322 | 0.6 | % | - | - | % | ||
Gain on Disposal | (1,264) | (0.3) | % | - | - | % | ||
Operating Income
|
9,115 | 2.4 | % | 19,490 | 4.4 | % | ||
Interest Income | 222 | 0.1 | % | 299 | 0.1 | % | ||
Interest Expense | (4,792) | (1.3) | % | (5,447) | (1.2) | % | ||
Non-Operating Income (Expense), net | (1,661) | (0.4) | % | (1,131) | (0.3) | % | ||
Other Income (Expense), net | (6,231) | (1.6) | % | (6,279) | (1.4) | % | ||
Income Before Taxes on Income | 2,884 | 0.8 | % | 13,211 | 3.0 | % | ||
Provision for Income Taxes | (270) | - | % | 2,457 | 0.5 | % | ||
Net Income
|
$ | 3,154 | 0.8 | % | $ | 10,754 | 2.5 | % |
Earnings Per Share of Common Stock: | ||||||||
Basic | $ | 0.13 | $ | 0.43 | ||||
Diluted | $ | 0.12 | $ | 0.43 | ||||
Average Number of Shares Outstanding: | ||||||||
Basic | 24,979 | 25,041 | ||||||
Diluted | 25,235 | 25,238 |
Condensed Consolidated Statements of Cash Flows | Three Months Ended | |||
(Unaudited) | September 30, | |||
(Amounts in Thousands) | 2024 | 2023 | ||
Net Cash Flow provided by Operating Activities | $ | 45,474 | $ | 12,801 |
Net Cash Flow provided by (used for) Investing Activities | 5,226 | (11,302) | ||
Net Cash Flow (used for) provided by Financing Activities | (52,954) | 13,985 | ||
Effect of Exchange Rate Change on Cash, Cash Equivalents, and Restricted Cash | 1,830 | (549) | ||
Net (Decrease) Increase in Cash, Cash Equivalents, and Restricted Cash | (424) | 14,935 | ||
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period | 78,779 | 43,864 | ||
Cash, Cash Equivalents, and Restricted Cash at End of Period | $ | 78,355 | $ | 58,799 |
(Unaudited) | ||||
Condensed Consolidated Balance Sheets |
September 30, 2024 |
June 30, 2024 |
||
(Amounts in Thousands) | ||||
ASSETS | ||||
Cash and cash equivalents | $ | 76,564 | $ | 77,965 |
Receivables, net | 264,036 | 282,336 | ||
Contract assets | 74,326 | 76,320 | ||
Inventories | 335,272 | 338,116 | ||
Prepaid expenses and other current assets | 32,496 | 44,682 | ||
Assets held for sale | - | 27,587 | ||
Property and Equipment, net | 275,674 | 269,659 | ||
Goodwill | 6,191 | 6,191 | ||
Other Intangible Assets, net | 2,880 | 2,994 | ||
Other Assets, net
|
81,617 | 82,069 | ||
Total Assets | $ | 1,149,056 | $ | 1,207,919 |
LIABILITIES AND SHARE OWNERS' EQUITY
|
||||
Current portion of borrowings under credit facilities | $ | 45,915 | $ | 59,837 |
Accounts payable | 216,704 | 213,551 | ||
Advances from customers | 35,616 | 30,151 | ||
Accrued expenses | 45,492 | 63,189 | ||
Liabilities held for sale | - | 8,594 | ||
Long-term debt under credit facilities, less current portion | 200,000 | 235,000 | ||
Long-term income taxes payable | - | 3,255 | ||
Other long-term liabilities | 57,571 | 53,881 | ||
Share Owners' Equity | 547,758 | 540,461 | ||
Total Liabilities and Share Owners' Equity | $ | 1,149,056 | $ | 1,207,919 |
Other Financial Metrics | ||||||
(Unaudited) | ||||||
(Amounts in Millions, except CCD) | ||||||
At or For the | ||||||
Three Months Ended | ||||||
September 30, |
June 30,
|
September 30, | ||||
2024 | 2024 | 2023 | ||||
Depreciation and Amortization | $ | 9.2 | $ | 9.5 | $ | 9.0 |
Cash Conversion Days (CCD) (1)
|
108 | 100 | 103 | |||
Open Orders (2)
|
$ | 594 | $ | 714 | $ | 907 |
Select Financial Results of Automation, Test and Measurement
|
||||
(Unaudited) | ||||
(Amounts in Millions)
|
||||
Three Months Ended | ||||
September 30, | ||||
2024 | 2023 | |||
Net Sales | $ | 2.1 | $ | 10.3 |
Operating Income (Loss) (1)
|
$ | 0.8 | $ | (0.2) |
Reconciliation of Non-GAAP Financial Measures | ||||
(Unaudited, Amounts in Thousands, except Per Share Data) | ||||
Three Months Ended | ||||
September 30, | ||||
2024 | 2023 | |||
Net Sales Growth (vs. same period in prior year) | (15) | % | 8 | % |
Foreign Currency Exchange Impact | - | % | 1 | % |
Constant Currency Growth | (15) | % | 7 | % |
Selling and Administrative Expenses, as reported | $ | 13,427 | $ | 16,052 |
Stock Compensation Expense | (2,072) | (1,693) | ||
SERP | (345) | 177 | ||
Adjusted Selling and Administrative Expenses | $ | 11,010 | $ | 14,536 |
Operating Income (Loss), as reported | $ | 9,115 | $ | 19,490 |
Stock Compensation Expense | 2,072 | 1,693 | ||
SERP | 345 | (177) | ||
Restructuring Expense | 2,322 | - | ||
Gain on Disposal | (1,264) | - | ||
Adjusted Operating Income | $ | 12,590 | $ | 21,006 |
Net Income (Loss), as reported | $ | 3,154 | $ | 10,754 |
Stock Compensation Expense, After-Tax | 1,571 | 1,284 | ||
Restructuring Expense, After-Tax | 1,761 | - | ||
Gain on Disposal, After-Tax | (959) | - | ||
Adjusted Net Income | $ | 5,527 | $ | 12,038 |
Diluted Earnings per Share, as reported | $ | 0.12 | $ | 0.43 |
Stock Compensation Expense | 0.06 | 0.05 | ||
Restructuring Expense | 0.07 | - | ||
Gain on Disposal | (0.03) | - | ||
Adjusted Diluted Earnings per Share | $ | 0.22 | $ | 0.48 |
Twelve Months Ended | ||||
September 30, | ||||
2024 | 2023 | |||
Operating Income | $ | 38,902 | $ | 93,648 |
Goodwill Impairment | 5,820 | - | ||
Stock Compensation Expense | 7,564 | 6,975 | ||
SERP | 1,202 | 759 | ||
Legal Recovery | (892) | (212) | ||
Restructuring Expense | 4,708 | - | ||
Asset Impairment and Gain on Disposal | 15,776 | - | ||
Adjusted Operating Income (non-GAAP) | $ | 73,080 | $ | 101,170 |
Tax Effect | 16,285 | 24,625 | ||
After-tax Adjusted Operating Income | $ | 56,795 | $ | 76,545 |
Average Invested Capital (1)
|
$ | 773,016 | $ | 738,096 |
ROIC | 7.3 | % | 10.4 | % |